Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2022, Vol. 16 ›› Issue (03): 285-288. doi: 10.3877/cma.j.issn.1674-0785.2022.03.017

• Review • Previous Articles     Next Articles

Progress in clinical application of Impella

Yue Zhang1, Gang Huang1, Yueting You1, Junbo Xu1,()   

  1. 1. Department of Cardiovascular Medicine, the Third People's Hospital of Chengdu; Affiliated Hospital of Southwest Jiaotong University; Chengdu Institute of Cardiovascular Diseases, Chengdu 610031, China
  • Received:2021-07-21 Online:2022-03-15 Published:2022-06-21
  • Contact: Junbo Xu

Abstract:

Impella is a ventricular assist device which can reduce left ventricular load, increase coronary blood flow, reduce myocardial oxygen consumption, and improve circulatory failure. In the past, it was commonly used in cardiogenic shock and high-risk percutaneous coronary intervention. Now, it is also used in myocarditis, cardiomyopathy, and heart failure. Impella causes many complications due to the fast operation of its axial flow pump and large catheter diameter. With the improvement of equipment and in-depth research, some new ideas are provided for the prevention and treatment of Impella complications. This paper reviews the progress in the application of impella in the cardiovascular field.

Key words: Imeplla, Ventricular assist device, Cardiovascular disease

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-51322622 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd